Pulmatrix, Inc. (PULM)

CIK 0001574235 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
FY-2025
Latest Q1-2026 8-K (2026-05-15) · 99.1
Latest FY-2025 8-K (2026-02-26) · 99.1
Q3-2025 8-K (2025-10-16) · 99.1
Q2-2025 8-K (2025-08-06) · 99.1
Q1-2025 —
FY-2024 8-K (2025-03-21) · 99.1
Q3-2024 8-K (2024-11-08) · 99.1
Q2-2024 8-K (2024-08-13) · 99.1
Q1-2024 8-K (2024-05-10) · 99.1
FY-2023 8-K (2024-03-28) · 99.1  |  8-K (2024-01-08) · 99.1 · 99.2
Q3-2023 8-K (2023-11-09) · 99.1
Q2-2023 8-K (2023-08-10) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Operations
Consolidated Statements of Stockholders' Equity
Consolidated Statements of Cash Flows
Notes
Accrued Expenses and Other Current Liabilities
Commitments and Contingencies
Common Stock
Cybersecurity Risk Management and Strategy Disclosure
—
Fair Value of Financial Instruments
—
Income Taxes
Insider Trading Arrangements
—
Insider Trading Policies and Procedures
—
Leases
Nature of The Business
—
Net (loss) Income Per Share
—
Net Income (loss) Per Share
—
Net Loss Per Share
Organization
—
Pay Vs Performance Disclosure
—
Preferred Stock
—
Prepaid Expenses and Other Current Assets
Property and Equipment, Net
Segment Reporting
Significant Agreements
Stock-based Compensation
Subsequent Events
Summary of Significant Accounting Policies and Recent Accounting Standards
Warrants